Centessa Pharmaceuticals plc (CNTA) Financials
CNTA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 641.8 million | 154.4 million |
| Dec. 31, 2025 | 687.5 million | 160.6 million |
| Sept. 30, 2025 | 448.3 million | 146.7 million |
| June 30, 2025 | 492.1 million | 147.2 million |
CNTA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -72.2 million | 10.6 million |
| Dec. 31, 2025 | -55.8 million | 7.9 million |
| Sept. 30, 2025 | -58.5 million | 7.2 million |
| June 30, 2025 | -22.6 million | 7.9 million |
CNTA Net Income
No data available :(
CNTA Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 276.6 million | 7.4 million | 8.1 million |
| Dec. 31, 2025 | 294.6 million | 7.6 million | 8.3 million |
| Sept. 30, 2025 | 246.2 million | 109.8 million | 8.4 million |
| June 30, 2025 | 250.7 million | 109.5 million | 8.6 million |
CNTA Shares Outstanding
CNTA Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 59.9 million | 19.9 million | - |
| Dec. 31, 2025 | 10996 | 54.5 million | 14.0 million | - |
| Sept. 30, 2025 | 234000 | 41.6 million | 12.2 million | - |
| June 30, 2025 | 126000 | 42.7 million | 11.9 million | - |
CNTA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 238599 |
| Dec. 31, 2025 | - | - |
| Sept. 30, 2025 | - | - |
| June 30, 2025 | - | 228674 |
CNTA Revenue by Segment
Graph available only for paid members. Upgrade to see it.
CNTA
Price: $39.72
52 week price:
Earnings Per Share: -1.78 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 66900
Market Capitalization: 6.2 billion